Test Price
2,800 AED✅ Home Collection Available
CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test
Executive Summary & Core Metrics
- Accuracy: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM to 11 PM)
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The CACNA1D gene test uses Next‑Generation Sequencing (NGS) on the Illumina platform to identify pathogenic variants in the CACNA1D gene, providing definitive molecular diagnosis for hereditary sinoatrial node dysfunction and bilateral sensorineural hearing loss (deafness). This advanced genetic analysis confirms mutations causing sinoatrial node dysfunction and deafness, enabling physicians to deliver personalized care and family support.
| Feature | Our Test (NGS) | Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity, full gene coverage | ~99% per base, may miss large deletions |
| Method | NGS on Illumina® platform | Chain‑termination sequencing |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2,800 AED | 3,200–4,000 AED |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize that a genetic diagnosis profoundly impacts patients and families. This CACNA1D test, when integrated with clinical and family history, clarifies the cause of sinoatrial node dysfunction and deafness, guiding personalized management and surveillance. Please do not discontinue any prescribed medication without consulting your doctor.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
Important Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Always discuss potential interactions with your healthcare provider before the test.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Active febrile illness, severe anemia (Hb <8 g/dL), or inability to provide a blood sample due to inaccessible veins.
- ER Red Flags: If you experience sudden worsening of hearing, syncope, chest pain, or severe dizziness after sample collection, seek emergency care immediately.
- For pediatric patients, a parent/legal guardian must be present and informed consent obtained as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the CACNA1D gene test used for?
The CACNA1D gene test confirms hereditary sinoatrial node dysfunction and deafness by detecting pathogenic mutations, helping determine prognosis and family risk.
2. How is the sample collected and how long to get results?
A blood draw (peripheral whole blood) or FTA card sample is collected at your home via our VIP mobile phlebotomy service. Results are available in 3–4 weeks with a comprehensive molecular report.
3. Is genetic counseling provided?
Yes, pre‑ and post‑test genetic counseling is included to interpret your results and pedigree analysis by a certified genetic counselor.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled in accordance with the highest privacy and security standards. ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139). Facility License No. 1143 issued by Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | CACNA1D Gene Sequencing Test (Sinoatrial Node Dysfunction & Deafness) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina® platform |
| ICD-10-CM Code | I45.5 (Sinoatrial node dysfunction), H90.5 (Sensorineural hearing loss, unspecified) |
| LOINC Code | 83018-4 (CACNA1D gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians